foxo4-dri senolytic animal model 2023 2024 Frontiers Senolytic therapeutics: An emerging treatment
Senolytic therapeutics: An emerging treatment modality for osteoarthritis ScienceDirect Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series JACC: Basic to Translational Science Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




